First, our healthcare team will assess your current treatment plan with compounded medications like tirzepatide or semaglutide, evaluating your weight loss goals and health status
Timing and Weekly Consistency Retatrutide has a half-life of approximately six days, which is why once-weekly dosing produces stable blood levels
Retatrutide Safety Monitoring Checklist Review current medications and medical history
Insulin treat patients The LixiLan-L trial [31] was a 30-week, double-blind trial, designed to confirm the superiority of IGlarLixi in comparison to glargine alone in patients with T2DM inadequately treated with a stable dose of insulin glargine and any other OAD
Potential Benefits of Retatrutide for Women Clinical Trial Evidence and Findings in Female Participants Hormonal and Metabolic Considerations for Women Safety Profile, Side Effects, and Guidance Current Availability and What to Discuss With Your GP Scientific References Frequently Asked Questions What Is Retatrutide and How Does It Work